4-117085218-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152402.3(TRAM1L1):c.176T>A(p.Val59Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,984 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152402.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAM1L1 | NM_152402.3 | c.176T>A | p.Val59Asp | missense_variant | 1/1 | ENST00000310754.5 | NP_689615.2 | |
LOC105377388 | XR_939103.3 | n.2572-1107A>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAM1L1 | ENST00000310754.5 | c.176T>A | p.Val59Asp | missense_variant | 1/1 | 6 | NM_152402.3 | ENSP00000309402.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251404Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135876
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461880Hom.: 1 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727242
GnomAD4 genome AF: 0.000112 AC: 17AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.176T>A (p.V59D) alteration is located in exon 1 (coding exon 1) of the TRAM1L1 gene. This alteration results from a T to A substitution at nucleotide position 176, causing the valine (V) at amino acid position 59 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at